News & Events

Filter Year   Keywords   > Submit

Page 1 2

PHASE 2a PILOT STUDY OF EB-1020 SR SHOWS STIMULANT-LIKE EFFICACY WITH LOWER RISK OF ABUSE

09 / 01 / 2014

EB-1020 SR Is a Norepinephrine & Dopamine-Preferring Triple Reuptake Inhibitor for All Subtypes of Adult Attention Deficit Hyperactivity Disorder (ADHD)

> Read More

 
Displaying records 51-53 of 53